Search For "dos"
Covid-19 fallout: SII signs deal with Astra Zeneca to manufacture vaccines
Updated : 5 years, 11 months ago IST
New Delhi [India], June 13 (ANI): Adar Poonawalla, CEO and Owner, Serum Institute of India (SII) on Saturday announced that his firm has signed a deal with Astra Zeneca to supply one billion doses of vaccine for low and middle-income countries before the end of 2020 to combat coronavirus.
Read More
Akshay-Kareena's 'Good Newwz' to re-release in Dubai on June 11
Updated : 5 years, 11 months ago IST
New Delhi [India], June 8 (ANI): Actor Akshay Kumar on Monday announced that his comedy flick 'Good Newwz' will be re-released in Dubai on June 11.
Read More
Building a green future: BMW Group Plant Chennai sets new benchmarks in su
Updated : 5 years, 11 months ago IST
Gurgram (Haryana) [India], June 5 (ANI/BusinessWire India): At BMW Group Plant Chennai, sustainability is a top priority. Through a host of initiatives, BMW Group Chennai is taking an active lead towards a green and sustainable future.
Read More
Four or more dosage of HCQ showed significant decline of covid19 among hea
Updated : 5 years, 11 months ago IST
New Delhi [India], June 1 (ANI): Citing noteworthy benefits of Hydroxychloroquine (HCQ) prophylaxis against coronavirus, the Indian Council of Medical Research (ICMR) has revealed that the consumption of four or more doses of the antimalarial drug- (HCQ), has shown a significant decline of C
Read More
Pregnancy at younger age lowers breast cancer risk by 30 pc
Updated : 5 years, 11 months ago IST
Washington D.C. [USA], May 30 (ANI): Pregnancy at a younger age (25 years and younger), lowers the risk of breast cancer by 30 per cent, suggests the findings of a recent study.
Read More
ICMR writes to WHO disagreeing with HCQ assessment, officials say internat
Updated : 5 years, 12 months ago IST
New Delhi [India], May 29 (ANI): After the Union Health Ministry expressed reservations about the World Health Organisation's (WHO) advisory to suspend hydroxychloroquine (HCQ) usage in treating COVID-19 patients, now, India's nodal government agency ICMR (Indian Council of Medical Research)
Read More
Study reveals pregnancy reprograms breast cells, reducing cancer risk
Updated : 5 years, 12 months ago IST
Washington D.C. [USA], May 29 (ANI): An early age of pregnancy (25 years and younger) is known to reduce the overall risk of breast cancer by over 30%, suggests findings of a recent study.
Read More
Villain in reel, hero in real; Sonu Sood explains why he asks migrants 'pa
Updated : 5 years, 11 months ago IST
New Delhi [India], May 28 (ANI): As Covid lockdown forced hundreds of thousands of migrant labourers to take to the path of their homes on foot, a voice echoed - "paidal kyon jaaogey mere dost? (why do you walk friend)" - and an actor who is predominantly known for villainous on-screen pe
Read More
Govts, drugmakers under pressure to roll out effective COVID vaccines
Updated : 6 years ago IST
Washington D.C. [USA], May 18 (ANI): Governments and drugmakers are considering ways how to roll out effective coronavirus vaccines and build capacity to make millions of its doses available in the United States starting as soon as this fall. Yet there isn't a guarantee that any of the most
Read More
69 corona patients recover in Chennai with traditional Indian treatment
Updated : 6 years ago IST
Chennai (Tamil Nadu) [India], May 16 (ANI): As many as 69 COVID-19 patients have been discharged from Chennai's Dwaraka Doss Goverdhan Doss Vaishnav College in four days after they recovered with the help of Western and Siddha medicines.
Read More
Under 'Operation Warp Speed' Trump hopes for COVID-19 vaccine by end of ye
Updated : 6 years ago IST
Washington DC [USA], May 16 (ANI): President Donald Trump on Friday said that the United States will be able to deliver a few hundred million doses of COVID-19 vaccine, under 'Operation Warp Speed', by the end of this year.
Read More
Trump administration failed to scale up in time to distribute COVID-19 dru
Updated : 6 years ago IST
Washington DC [USA], May 15 (Sputnik/ANI): There are not enough doses of the coronavirus trial drug remdesivir because the Trump administration failed to ramp up production and lacks a distribution plan, former government vaccine developer Rick Bright said on Thursday.
Read More